The effect of L-carnitine on sperm motility in azospermic patients

The effect of L-carnitine on sperm motility in azospermic patients who are candidate for sperm recovery

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT138903294181N2

Enrollment

Registered

2011-07-12

Start date

2011-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Azospermia. Male infertility

Interventions

Intervention 1: oral L-carnitine 1gr/12h, for 3 mounth. Intervention 2: oral placebo/12h for 3 months.

Treatment - Drugs

Placebo

oral L-carnitine 1gr/12h, for 3 mounth

oral placebo/12h for 3 months

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients candidate for sperm recovery. Exclusion criteria: increased Follicle-Stimulating Hormone(>*2); positive drug history (except L carnitine); systemic disease such as renal failure.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sperm motility. Timepoint: 2 mounth. Method of measurement: microscope.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Morsal Aghavali

Tabriz University of Medical Sciences

draghavali@yahoo.com+98 914 382 4213

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026